Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 80.00
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

23 Feb 2018 09:06

RNS Number : 7741F
British Smaller Companies VCT PLC
23 February 2018
 

 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 31 December 2017

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2017. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company has continued to make good progress with total return rising to 214.8 pence per ordinary share; Net Asset Value ("NAV") stood at 78.4 pence per ordinary share. This is an increase of 1.4 pence per ordinary share in the quarter equivalent to 1.8% growth in the period.

Performance

31 December 2017

Movement

30 September 2017

Net Assets (£m)

85.1

1.1

84.0

NAV per share (PPS)

78.4p

1.4p

77.0p

Cumulative dividends paid (PPS)

136.4p

-

136.4p

Total Return (PPS)

214.8p

1.4p

213.4p

Shares in issue

108,607,183

(500,000)

109,107,183

 

The total return at 31 December 2017, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 214.8 pence per ordinary share compared to 213.4 pence per ordinary share at 30 September 2017.

The unaudited NAV per ordinary share as at 31 December 2017 was 78.4p pence per ordinary share (30 September 2017: 77.0 pence per ordinary share). Cumulative dividends paid were unchanged at 136.4 pence per ordinary share (30 September 2017: 136.4 pence per ordinary share).

Shares in issue

On 19 December 2017 the Company purchased 500,000 ordinary shares of 10 pence each at a price of 73.65 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 December 2017 was 108,607,183 (30 September 2017: 109,107,183). In addition, at 31 December 2017 the Company held 4,807,999 ordinary shares in treasury (30 September 2017: 4,307,999).

Net assets

Net assets at 31 December 2017 comprised the following:

£000

% of net assets

Unquoted investments at fair value

54,459

64.0

Quoted investments at bid price

2,205

2.6

Total investments

56,664

66.6

Fixed income government securities

708

0.8

Quoted funds

1,893

2.2

Cash and cash equivalents

24,378

28.6

Other net current assets

1,477

1.8

Net assets

85,120

100.0

 

The investment portfolio at 31 December 2017 was comprised as follows:

Valuation

£000

Valuation as a % of net assets

Intelligent Office

 4,960

5.8

ACC Aviation

 4,672

5.5

Mangar Health Limited

 3,962

4.7

GTK (Holdco) Limited

 2,964

3.5

Springboard Research Holdings Limited

 2,896

3.4

Matillion Limited

2,728

3.2

Business Collaborator Limited

 2,703

3.2

Gill Marine Holdings Limited

 2,569

3.0

Deep-Secure Limited

 2,550

3.0

KeTech Enterprises Limited

2,336

2.7

32,340

38.0

Other investments

24,324

28.6

Total investments

56,664

66.6

 

There were no investments during the period.

In the quarter to 31 December 2017 the realisation and repayment of investments generated proceeds of £1.4 million.

 

Portfolio Performance

Over the quarter to 31 December 2017 aggregate unrealised portfolio valuations have increased by £1.6 million. There were strong performances in the quarter from the investments in GTK, Matillion, Deep-Secure and Business Collaborator, offset by reductions from RMS, Sipsynergy and DisplayPlan.

The Board continues to follow its policy of maintaining a diversified portfolio. At 31 December 2017, only two investments represented more than 5 per cent of the Company's NAV.

Outlook

Your Board remains encouraged by the increase in investment opportunities that it is seeing, although the conversion of this pipeline to new investments continues to be hampered by the slow granting of advance assurance from HMRC. The Company has just received advance assurances for two new investments (£3.3 million) which it is hoped will complete in the near future, and is awaiting assurance on one further investment of £1.3 million.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

 

23 February 2018

 

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 886 2715

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTPGUCUPUPRUBW
Date   Source Headline
3rd Apr 20247:58 amRNSIssue of Equity and Close of Offers
26th Mar 202411:11 amRNSTransaction in Own Shares and Total Voting Rights
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNS3rd Quarter Results
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:23 amRNSIssue of Equity
18th Dec 20234:02 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
8th Dec 20239:47 amRNSPayment of Dividend and Issue of Equity
24th Nov 20237:00 amRNSHalf-year Report
26th Oct 20231:34 pmRNSDividend Declaration
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:20 amRNSTransaction in Own Shares and PDMR
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
14th Sep 202310:28 amRNSResult of AGM
14th Sep 202310:28 amRNSResult of General Meeting
13th Sep 20237:00 amRNS1st Quarter Results
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
28th Jul 202310:00 amRNSDirector/PDMR Shareholding
28th Jul 202310:00 amRNSPayment of Dividend and Issue of Equity
27th Jun 20237:45 amRNSTransaction in Own Shares
21st Jun 20231:00 pmRNSPublication of Circular
16th Jun 202312:00 pmRNSAnnual Financial Report
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:23 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:42 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNS3rd Quarter Results
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSDirector/PDMR Shareholding
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:48 amRNSTransaction in Own Shares
6th Dec 20229:58 amRNSOffer Update
6th Dec 20229:58 amRNSOffer Update
30th Nov 202212:30 pmRNSPublication of a Prospectus
30th Nov 202212:30 pmRNSPublication of a Prospectus
25th Nov 20229:30 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.